AC
MEDP icon

Ascend Capital’s Medpace MEDP Stock Holding History

Ascend Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$975K Buy
+16,266
New +$890K 0.05% 152

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ascend Capital's MEDP Position: Q3 2018 in Review

Ascend Capital opened a new position in Medpace (MEDP) in Q3 2018: 16,266 shares worth $975K. The stake represents 0.05% of the portfolio and ranks #152 among its holdings.

207 funds tracked by Wall St. Rank hold MEDP as of Q3 2018.

  • Ascend Capital held 16,266 shares of Medpace worth $975K as of Q3 2018.
  • Medpace was a new Ascend Capital position in Q3 2018.
  • Medpace made up 0.05% of Ascend Capital's portfolio in Q3 2018, its #152 holding.
  • 207 funds tracked by Wall St. Rank held Medpace as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.